| |
|
|
|
|
|
When used by the recommended techniques, latex particles in the reagent will agglutinate (clump) in the presence of Toxoplasma gondii antibodies. No agglutination generally indicates absence of the Toxoplasma antibody
|
Company:
Date:
March 02, 2009
|
|
|
|
|
|
|
|
|
|
Lorne Toxoplasmosis Latex Test reagent consists of latex particles sensitised with Toxoplasma gondii antigens. All the reagents are supplied at optimal dilution for use with all techniques without need for further dilution or addition. For lot reference number and expiry date see Vial Labels.
|
Company:
Date:
March 02, 2009
|
|
|
|
|
|
|
|
|
|
5’-Nucleotidase (5’-NT) assay kit is for determination of 5’-NT activity in human serum samples. 5’-NT is an enzyme catalyzing the hydrolysis of nucleoside- 5’-monophosphates to nucleosides and inorganic phosphate. The enzyme is widely distributed in human and animal tissues. The activity present in sera is released from the membrane of liver cells by bile salts and has been used as a marker for liver disease 1. Increased enzyme levels in sera are associated with certain forms of liver disease, such as intra- or extra-hepatic obstruction and particularly in cases of hepatic carcinoma as well
|
Company:
Date:
July 06, 2009
|
|
|
|
|
|
|
|
|
|
Adenosine deaminase (ADA) assay kit is for the determination of ADA activity in human serum, plasma, pleural fluid and cerebrospinal fluid (C.S.F.) samples. ADA is an enzyme catalyzing the deamination reaction from adenosine to inosine. The enzyme is widely distributed in human tissues, especially high in T lymphocytes. Elevated serum ADA activity has been observed in patients with acute hepatitis, alcoholic hepatic fibrosis, chronic active hepatitis, liver cirrhosis, viral hepatitis and hepatoma.1,2 Increased ADA activity was also observed in patients with tuberculous effusions.3 Determina
|
Company:
Date:
July 06, 2009
|
|
|
|
|
|
|
|
|
|
The α-L-fucosidase (AFU) assay kit is for the determination of AFU activity in patient serum samples. AFU is a lysosomal enzyme involved in the degradation of a diverse group of naturally occurring fucoglycoconjugates. Serum AFU activity is considered a useful marker of hepatocellular carcinoma (HCC). Increased AFU levels in serum are an early indication of HCC. Though measurement of serum fetoprotein (AFP) is a common practice for early detection of HCC, AFP assay alone suffers from its low specificity and sensitivity due to the fact that not all HCC secrete AFP. AFP levels may be normal in
|
Company:
Date:
July 06, 2009
|
|
|
|
|
|
|
|
|
|
Using 2 discrete antigens per slide wells, this assay screens for both Anaplasma phagocytophilum and Ehrlichia chaffeensis antibody simultaneously. Ehrlichia canis is also available (E21G-120)for canine serum testing.
|
Company:
Date:
June 08, 2010
|
|
|
|
|
|
|
|
|
|
Using 2 discrete antigens per slide wells, this assay screens for both Anaplasma phagocytophilum and Ehrlichia chaffeensis antibody simultaneously. Ehrlichia canis is also available (E21G-120)for canine serum testing.
|
Company:
Date:
June 08, 2010
|
|
|
|
|
|
|
|
|
|
Anaplasma phagocytophilum is a tick-borne pathogen of both humans and companion animals. The IFA IgG test contains infected cells for ease in discrimination by IFA.
|
Company:
Date:
June 08, 2010
|
|
|
|
|
|
|
|
|
|
Staphylococcus (Staph) Test Kit
|
Company:
Date:
March 02, 2009
|
|
|
|
|
|
|
|
|
|
The Anthrax protective antigen (PA) IgG ELISA is intended for use in the evaluation of patient’s immune status or exposure to Anthrax. ELISA test for the detection of IgG antibody to Anthrax Protective Antigen (PA) can be used to study the efficacy of experimental anthrax vaccine and the exposure to this antigen. Because B. anthracis has a high probability for use as an agent in biologic terrorism, many centers are involved in studying the epidemiological and laboratory diagnostic of this bacterium. Human anthrax has three major clinical forms: cutaneous, inhalation, and gastrointestinal. Cu
|
Company:
Date:
July 06, 2009
|
|
|
|
|
|